Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-51.3
Price to sales ratio
2 326.88

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
444
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
236.56 USD-1.02%+3.36%-17.82%-47.73%31.65 B USD
485
RPRX
Royalty Pharma plc - Class A Ordinary Shares
61.92 USD+0.19%+2.30%+3.36%+66.18%27.65 B USD
497
BNTX
BioNTech SE - American Depositary Shares
111.40 USD-1.03%+0.43%+20.56%+9.51%26.73 B USD
501
INSM
Insmed Incorporated - Common Stock
121.39 USD-2.41%-2.91%+16.74%-25.09%26.51 B USD

Frequently asked questions about Roivant Sciences Ltd. Common Shares

What is the Roivant Sciences Ltd. Common Shares stock price today?

The current price of Roivant Sciences Ltd. Common Shares (ROIV) is 37.58. Over the past 24 hours, the stock has changed by +2.26%. Follow the ROIV chart for real-time price dynamics.

What is the stock ticker of Roivant Sciences Ltd. Common Shares?

Roivant Sciences Ltd. Common Shares trades under the ticker ROIV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Roivant Sciences Ltd. Common Shares stock going up?

ROIV has changed by +1.49% over the last week, +10.89% over the last month, and +105.24% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Roivant Sciences Ltd. Common Shares?

Roivant Sciences Ltd. Common Shares currently has a market capitalization of 27.14 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Roivant Sciences Ltd. Common Shares earnings last quarter?

Last quarter, Roivant Sciences Ltd. Common Shares reported earnings of -0.26 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Roivant Sciences Ltd. Common Shares revenue for the last quarter?

Roivant Sciences Ltd. Common Shares reported quarterly revenue of 1.44 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

How many employees does Roivant Sciences Ltd. Common Shares have?

As of the latest available data, Roivant Sciences Ltd. Common Shares has 721 employees. Workforce size can provide additional context about the company's scale and operations.

What is Roivant Sciences Ltd. Common Shares EBITDA?

Roivant Sciences Ltd. Common Shares EBITDA is -365.79 M, and its EBITDA margin is -25.37 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Roivant Sciences Ltd. Common Shares stock?

You can buy Roivant Sciences Ltd. Common Shares (ROIV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Roivant Sciences Ltd. Common Shares stock?

Investing in Roivant Sciences Ltd. Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ROIV chart and related analysis on metatrader.com as part of your research.

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

News